Aardvark Therapeutics, Inc. Common Stock AARD · Stock Open Aardvark Therapeutics, Inc. Common Stock in new tab
Aardvark Therapeutics, Inc. Common Stock Analysis (AARD)
Is Aardvark Therapeutics, Inc. Common Stock a good investment? Aardvark Therapeutics, Inc. Common Stock (AARD) is currently trading at 5.70 USD. Market analysts have a consensus price target of 15.44 USD. This suggests a potential upside from current levels.
Earnings Schedule: Aardvark Therapeutics, Inc. Common Stock is expected to release its next earnings report on Aug. 12, 2026. The market consensus estimate for Forward EPS is -3.24.
Investor FAQ
Does Aardvark Therapeutics, Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Aardvark Therapeutics, Inc. Common Stock?
Aardvark Therapeutics, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Aug. 12, 2026. The company currently has a trailing EPS of -3.47.
Company Profile
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Community Discussion